UNCY - Unicycive Therapeutics, Inc.
6.59
-0.240 -3.642%
Share volume: 692,030
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
-0.24
-0.04%
Summary score
41%
Profitability
50%
Dept financing
31%
Liquidity
58%
Performance
31%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
102.63%
Return on assets
-33.58%
Return on sales
-603.27%
Return on invested capital
106.28%
Total debt ratio
71.79%
Debt ratio change over timeo
0.62%
Current Ratio
2.84%
Quick Ratio
2.85%
Cash Position Ratio
2.42%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-5.56%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
42.81%
Debt ratio change over timeo
0%
Current Ratio
2.73%
Quick Ratio
0%
Cash Position Ratio
2.22%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.4%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
25.94%
Debt ratio change over time
0%
Current Ratio
3.83%
Quick Ratio
0%
Cash Position Ratio
3.25%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
50.22%
Return on assets
-173.8%
Return on sales
-423.99%
Return on invested capital
-5.57%
Total debt ratio
61.88%
Debt ratio change over time
0.62%
Current Ratio
1.48%
Quick Ratio
1.24%
Cash Position Ratio
1.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UNCY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 102.63% | 13.23% | 9.84% | 26.17% |
| Return on assets | -33.58% | 4.59% | 3.2% | 1.81% |
| Return on sales | -603.27% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 106.28% | 8.51% | 10.28% | 4.83% |
| Profitability | 50% | 55% | 43% | 38% |
| Total debt ratio | 71.79% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | 0.62% | -16.59% | -73.52% | 21.11% |
| Dept financing | 20% | 22% | 16% | 50% |
| Current Ratio | 2.73% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.22% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 20% | 24% | 16% |
| Short-term ratios | UNCY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -5.56% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 42.81% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 36% | 20% | 15% | 25% |
| Current Ratio | 2.73% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 2.22% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 39% | 36% | 23% |